CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.

by Yuyan Zhu, Huayan Hou, William V Nikolic, Jared Ehrhart, Elona Rrapo, Paula Bickford, Brian Giunta, Jun Tan
Published 2008-05-01

Timely Management of Obstructive Prosthetic Valve Thrombosis

by Elona Rrapo Kaso, MD, Steve A. Noutong, MD, LeAnn N. Denlinger, MD, Mohammed Morsy, MD, Christopher M. Kramer, MD
Published 2019-12-01